Cantor Fitzgerald analyst Olivia Brayer maintained a Buy rating on Vertex Pharmaceuticals (VRTX – Research Report) yesterday and set a price target of $480.00. The company’s shares closed ...

A surprisingly efficient and powerful Chinese AI model has taken the technology industry by storm. It’s called DeepSeek R1, and it’s rattling nerves on Wall Street. The new AI model was ...

DeepSeek, a one-year-old startup, revealed a stunning capability last week: It presented a ChatGPT-like AI model called R1, which has all the familiar abilities, operating at a fraction of the ...

The US military and intelligence services are eager to harness the potential of AI, and firms are developing new technology to enable them. While many industries can experiment with AI freely and ...

ForbesFive Reasons Why Developers Love DigitalOceanBy Janakiram MSV In comparison to competitors like Amazon Bedrock, Microsoft Azure AI or Google Vertex AI, DigitalOcean’s platform offers a ...

Morgan Stanley lowered the firm’s price target on Vertex Pharmaceuticals (VRTX) to $450 from $456 and keeps an Equal Weight rating on the shares. The launch of Casgevy, the first gene-editing ...

Experts predicted that 2025 would be the year AI agents go mainstream, and OpenAI is delivering on that forecast. On Thursday, OpenAI unveiled Operator, a system that can use a web browser to do ...

Have there been human rights abuses in Xinjiang? Ask ChatGPT, the artificial intelligence (AI) chatbot, and you’ll receive an unambiguous yes. Put the same question to DeepSeek, a Chinese ...

DeepSeek’s sudden emergence is leading to a re-evaluation of the AI market and is a major challenge to US dominance, as Science Correspondent Martin Stew explains Tech stocks have tumbled in the ...

Right now, I’m wondering whether the AI PC falls into that bucket, at least for the everyday consumer. Touted as the future of computing, these laptops and desktops seek to inject the power of ...